翻译1(4-6).docxVIP

图表：Figure 2. (A) Erythropoietin response for all subjects, plotted by numerator and denominator of the measure. Subjects were characterized by value of the erythropoietin response measure, which was categorized into quartiles (1st (○) 2nd (■) 3rd (▲) and 4th (◆)). For each subject, the quartile of erythropoietin response was plotted by the increase in Epoetin alfa dose at randomization (denominator of the response measure) on the horizontal axis, and hematocrit response (numerator of the response measure, which was the hematocrit slope derived from a simple linear regression of study week on hematocrit) on the vertical axis.(B) Erythropoietin response as a function of prestudy (baseline) Epoetin alfa dose. Erythropoietin response values (●) on the vertical axis are shown plotted against baseline Epoetin alfa dose (×1000 U/wk) on the horizontal axis. A histogram showing the number of subjects at each level of baseline dose is shown in the background.图2（A）所有受试者对促红细胞生成素的反应，由测量的分子和分母绘制。受试者根据促红细胞生成素反应的测量值，归类为一组四分位数（第1（○）第二（■）第三（▲）和第四（◆））。对于每个受试者，促红细胞生成素反应的四分位作图通过随机增加促红素α剂量（反应测量的分母）作为水平轴，以及血细胞比容反应（反应测量分子，从对研究的血细胞比容斜率的简单的线性回归获得）作为纵轴。（B）促红细胞生成素的反应作为促红素α剂量的前期研究（基础）的函数。以促红细胞生成素的反应值（●）为纵轴，以基础促红素α剂量（×1000 U/wk）为横轴作图。在背景中的柱状图显示在每一级的基础剂量的受试者数量。Figure 3. Association between erythropoietin response quartile, and all-cause 1-yr mortality assessed using a Cox proportional hazard model. (A) Results from models at three levels of adjustment are plotted: unadjusted (●), case-mix (■), and full (△). (B) Results are presented in a tabular format. CI, confidence interval图3。采用Cox比例风险模型，评估促红细胞生成素的反应四分位数和全因1年死亡率之间关联。（A）根据模型结果在三个调整水平上的作图：未调整（●），病例组合（■），和全（△）。（B）结果显示在表格格式。 CI，置信区间Figure 4. Lack of association between baseline Epoetin alfa dose and all-cause 1-yr mortality within each erythropoietin response quartile. A Cox proportional hazard model was used to evaluate the association between baseline Epoetin alfa dose (U) and mortality within quartiles of erythropoietin response. The hazard rat